{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T14:02:21Z","timestamp":1775570541368,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,12]]},"DOI":"10.7759\/cureus.103484","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T18:16:21Z","timestamp":1770920181000},"source":"Crossref","is-referenced-by-count":1,"title":["An Unlikely Culprit: Novel Case of Vancomycin Oral Solution-Induced Agranulocytosis"],"prefix":"10.7759","author":[{"given":"Ryan","family":"Azarkhail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uchemdi","family":"Nduka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haaroon","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prasad","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3892\/br.2021.1490","article-title":"Mechanisms of gram-positive vancomycin resistance (Review)","volume":"16","author":"Selim S","year":"2022","unstructured":"Selim S. Mechanisms of gram-positive vancomycin resistance (Review). Biomed Rep. 2022, 16:7. 10.3892\/br.2021.1490","journal-title":"Biomed Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/idr15020019","article-title":"A case of oral-vancomycin-induced rash in a patient with acute kidney injury","volume":"15","author":"Cardozo M","year":"2023","unstructured":"Cardozo M, Parmar AS, Rueda Prada L, Shweta F. A case of oral-vancomycin-induced rash in a patient with acute kidney injury. Infect Dis Rep. 2023, 15:180-187. 10.3390\/idr15020019","journal-title":"Infect Dis Rep"},{"key":"ref3","article-title":"Vancomycin","author":"Patel S","year":"2025","unstructured":"Patel S, Preuss CV, Bernice F. Vancomycin. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/9919464","article-title":"Prevalence, antibiotic resistance, and genetic diversities of Clostridioides difficile-contaminated meat nuggets in Isfahan, Iran","volume":"9919464","author":"Ghorbani Filabadi P","year":"2022","unstructured":"Ghorbani Filabadi P, Rahimi E, Ameri M. Prevalence, antibiotic resistance, and genetic diversities of Clostridioides difficile-contaminated meat nuggets in Isfahan, Iran. J Food Quality. 2022, 9919464:10.1155\/2022\/9919464","journal-title":"J Food Quality"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/3524091","article-title":"Examining the extent of contamination, antibiotic resistance, and genetic diversity of Clostridioides (Clostridium) difficile strains in meat and feces of some native birds of Iran","volume":"2023","author":"Ansarian Barezi A","year":"2023","unstructured":"Ansarian Barezi A, Shakerian A, Rahimi E, Esfandiari Z. Examining the extent of contamination, antibiotic resistance, and genetic diversity of Clostridioides (Clostridium) difficile strains in meat and feces of some native birds of Iran. Biomed Res Int. 2023, 2023:3524091. 10.1155\/2023\/3524091","journal-title":"Biomed Res Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkab231","article-title":"Mechanisms of antibiotic resistance of Clostridioides difficile","volume":"76","author":"Wickramage I","year":"2021","unstructured":"Wickramage I, Spigaglia P, Sun X. Mechanisms of antibiotic resistance of Clostridioides difficile. J Antimicrob Chemother. 2021, 76:3077-3090. 10.1093\/jac\/dkab231","journal-title":"J Antimicrob Chemother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab549","article-title":"Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults","volume":"73","author":"Johnson S","year":"2021","unstructured":"Johnson S, Lavergne V, Skinner AM, Gonzales-Luna AJ, Garey KW, Kelly CP, Wilcox MH. Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults. Clin Infect Dis. 2021, 73:e1029-e1044. 10.1093\/cid\/ciab549","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.17834","article-title":"Oral vancomycin for prevention of recurrent Clostridioides difficile infection: a randomized clinical trial","volume":"8","author":"Keating JA","year":"2025","unstructured":"Keating JA, Xu T, Graham MB, et al.. Oral vancomycin for prevention of recurrent Clostridioides difficile infection: a randomized clinical trial. JAMA Netw Open. 2025, 8:e2517834. 10.1001\/jamanetworkopen.2025.17834","journal-title":"JAMA Netw Open"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30751-X","article-title":"Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b\/4 trial","volume":"18","author":"Guery B","year":"2018","unstructured":"Guery B, Menichetti F, Anttila V-J, et al.. Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b\/4 trial. Lancet Infect Dis. 2018, 18:296-307. 10.1016\/S1473-3099(17)30751-X","journal-title":"Lancet Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2018.08.003","article-title":"Oral vancomycin versus metronidazole for the treatment of Clostridioides difficile infection: meta-analysis of randomized controlled trials","volume":"24","author":"Igarashi Y","year":"2018","unstructured":"Igarashi Y, Tashiro S, Enoki Y, et al.. Oral vancomycin versus metronidazole for the treatment of Clostridioides difficile infection: meta-analysis of randomized controlled trials. J Infect Chemother. 2018, 24:907-914. 10.1016\/j.jiac.2018.08.003","journal-title":"J Infect Chemother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P583","article-title":"Vancomycin-induced neutropenia: is it dose- or duration-related?","volume":"45","author":"Black E","year":"2011","unstructured":"Black E, Lau TT, Ensom MH. Vancomycin-induced neutropenia: is it dose- or duration-related?. Ann Pharmacother. 2011, 45:629-638. 10.1345\/aph.1P583","journal-title":"Ann Pharmacother"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/03000605231156761","article-title":"A rare case of infant eosinophilia induced by oral vancomycin: a case report and literature review","volume":"51","author":"Wu Y","year":"2023","unstructured":"Wu Y, Yin W, Guo S, Wang F. A rare case of infant eosinophilia induced by oral vancomycin: a case report and literature review. J Int Med Res. 2023, 51:3000605231156761. 10.1177\/03000605231156761","journal-title":"J Int Med Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.931647","article-title":"Neutropenia, thrombocytopenia, and eosinophilia: an unusual triad in a patient on long-term vancomycin therapy","volume":"22","author":"Lintel H","year":"2021","unstructured":"Lintel H, Saffaf M. Neutropenia, thrombocytopenia, and eosinophilia: an unusual triad in a patient on long-term vancomycin therapy. Am J Case Rep. 2021, 22:e931647. 10.12659\/AJCR.931647","journal-title":"Am J Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.909956","article-title":"Agranulocytosis induced by vancomycin. Case report and literature review","volume":"19","author":"di Fonzo H","year":"2018","unstructured":"di Fonzo H, Villegas Gutsch M, Castroagudin A, Cabrera MV, Mazzei ME, Rueda D. Agranulocytosis induced by vancomycin. Case report and literature review. Am J Case Rep. 2018, 19:1053-1056. 10.12659\/AJCR.909956","journal-title":"Am J Case Rep"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26146584","article-title":"A puerperal patient with leukopenia during vancomycin administration: a case report and review of the literature","volume":"26","author":"Tulic L","year":"2025","unstructured":"Tulic L, Ivanovic K, Tulic I, Vrzic-Petronijevic S, Ivanovic S, Bratic D, Petronijevic M. A puerperal patient with leukopenia during vancomycin administration: a case report and review of the literature. Int J Mol Sci. 2025, 26:6584. 10.3390\/ijms26146584","journal-title":"Int J Mol Sci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1G436","article-title":"Epidemiology of vancomycin-induced neutropenia in patients receiving home intravenous infusion therapy","volume":"40","author":"Pai MP","year":"2006","unstructured":"Pai MP, Mercier RC, Koster SA. Epidemiology of vancomycin-induced neutropenia in patients receiving home intravenous infusion therapy. Ann Pharmacother. 2006, 40:224-228. 10.1345\/aph.1G436","journal-title":"Ann Pharmacother"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/pharmacy12010038","article-title":"Two cases of vancomycin-induced neutropenia","volume":"12","author":"Ganaja K","year":"2024","unstructured":"Ganaja K, Scoular S, Hemmer S. Two cases of vancomycin-induced neutropenia. Pharmacy (Basel). 2024, 12:38. 10.3390\/pharmacy12010038","journal-title":"Pharmacy (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1Q467","article-title":"Severe neutropenia following a prolonged course of vancomycin that progressed to agranulocytosis with drug reexposure","volume":"46","author":"Duff JM","year":"2012","unstructured":"Duff JM, Moreb JS, Muwalla F. Severe neutropenia following a prolonged course of vancomycin that progressed to agranulocytosis with drug reexposure. Ann Pharmacother. 2012, 46:e1. 10.1345\/aph.1Q467","journal-title":"Ann Pharmacother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/459070-an-unlikely-culprit-novel-case-of-vancomycin-oral-solution-induced-agranulocytosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T18:16:21Z","timestamp":1770920181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/459070-an-unlikely-culprit-novel-case-of-vancomycin-oral-solution-induced-agranulocytosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.103484","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,12]]}}}